Web www.globalrph.com
Home Back *Drug Tables Disclaimer IV Dilutions *Health topics* Professional Resource 
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

HEPARIN Sodium
Usual Diluents
D5W,  NS
Standard Dilutions   [Amount of drug]  [Infusion volume]  [Infusion rate]
[25,000 units] [250 ml] [Titrate]
Loading dose:
Give IV-push or add to 50 ml D5W. 
Stability / Miscellaneous
EXP: 1 DAY (RT). 

Cautions: active hemorrhage, acute CVA, History of thrombocytopenia, baseline labs: PT > 15 ; PTT >48; or Platelets < 100,000 

Monitoring: PTT q6 to 8 hours following heparin therapy initiation or change in infusion until 2 consecutive therapeutic PTT levels are achieved at a consistent rate of infusion. Once the patient is stabilized, a PTT level should be checked qam. If a patient's PTT does not change significantly from baseline after 2 legitimate attempts to increase dose, consider heparin resistance (antithrombin III deficiency). 

Baseline labs: PT, PTT, CBC (Hgb, Hct, platelet count). QOD labs: Hgb, Hct, Platelets. 

Labwork requiring physician attention: (1) PTT > 100 sec (2) Platelet count < 100,000 or 40% decrease (3) INR > 3.5 (4) Hemoglobin decrease > 2 gm/dl. 
Remember: The most significant factor in reducing recurrent thrombo-embolism is reaching a therapeutic PTT in < 24 hours. 
Heparin induced thrombocytopenia: Consider changing to a direct thrombin inhibitor such as Lepirudin.
 


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.